ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2527

Increased Prevalence of Subclinical Atherosclerosis in Moderate-Severe Plaque Psoriasis Patients

Nuria Vegas-Revenga1, José Luis Martín-Varillas1, Susana Armesto2, Marcos A González- López3, Virginia Portilla2, Patricia Fuentevilla1, Javier Rueda-Gotor2, Carlos Fernández-Díaz1, Lucia C. Domínguez-Casas1, Belén Atienza-Mateo1, Jose L. Hernández4, Ricardo Blanco1, Miguel Angel González-Gay1 and Alfonso Corrales1, 1Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 2Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 3Dermatology, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain, 4Internal Medicine, Hospital Universitario Marqués de Valdecilla. IDIVAL. Santander. Universidad de Cantabria. Spain, Santander, Spain

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Atherosclerosis, Cardiovascular disease, Psoriatic arthritis and ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster III: Outcomes, Outcome Measures, and Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Surrogate markers of subclinical atherosclerosis and cardiovascular (CV) mortality such as carotid plaques (CP), arterial stiffness (AS) and carotid intima-media thickness (c-IMT), have been studied by carotid ultrasound (US) examination. In most studies done before, the results have shown an increased prevalence of CP and high values of c-IMT associated to greater CV risks. The same happens with the pulse wave velocity (PWV), which has become the gold standard to determine AS.

Our aim was to compare the prevalence of CP, PWV and c-IMT measurements between patients with moderate- severe psoriasis and the general population.

Methods: A cross-sectional study that included 40 patients with moderate- severe psoriasis (PASI>10, BAS>10 %), that fulfilled definitions for initiating treatment with a biological agent according to the Clinical Practice guidelines and 40 age-, sex- and traditional CV risk factors- matched healthy control subjects. Psoriatic arthritis (PsA) was present in 11 of 40 patients. Patients with history of CV events, diabetes mellitus, and chronic kidney disease or body max index> 35 were excluded. US was performed in the common carotid by a MyLab 70 scanner (Esaote; Genoa, Italy), QAS-RF and Q-IMT Maastricht (Holland). The results were obtained according to the Manheim Consensus Conference criteria. Statistical analysis: Qualitative data were expressed as number and percentages and quantitative data as mean (SD). Student’s t test or Mann-Whitney U were used to compare continuous variables, as appropriate. Chi2 test or Fisher test were used for qualitative variables.

Results: The main data of the patients are summarized in the TABLE. It is important to highlight that the study was based on a young population (mean age <40 years). Thus, the two groups did not present significant differences regarding the classic CV risks factors and other parameters studied, except for high sensitivity C -reactive protein (hsCRP).

As expected given the age of the group, CV risk measured by SCORE was low (0%) in most patients, with a mean of 0.2 (in the plaque psoriasis group) and 0.15 in the control group. No patient had a high-very high CV risk as measured by SCORE (≥ 5%). Patients with psoriasis had a long-standing disease (17.05 ± 11.63 years). The presence of carotid plaques was found in a total of 10 patients with plaque psoriasis (25%), 5 of them had bilateral plaques) and one in the control group (2.5%) without bilateral plaques), p <0.003. Even if patients with psoriasis had a higher PWV (6.33 m/sec) and c-IMT (0.579 mm) compared to the control group (6.13 m/sec and 0.549 mm), the difference was not significant (p = 0.72 and p = 0.17). It could be explained by the age of the study population and the sample size.

Conclusion: Moderate- severe psoriasis is associated with increased prevalence of CP, but PWV and c-IMT shows no differences.


TABLE


Variable


Plaque Psoriasis

( n = 40)

Controls


( n = 40 )

P

Age: Mean (SD)

37.68 (11.83)

38.63 (11.83)

0.75

Sex (Male): n (%)

18 (45)

18 (45)

1.0

Psoriasis duration (years): Mean (SD)

17.05 (11.63)

ND

–

BSA: Mean (SD)

38.99 (17.08)

ND

–

PASI: Mean (SD)

19.33 (8.89)

ND

–

hsCRP (mg/L): Mean (SD)

3.26 (3.31)

1.69 (2.62)

0.001

ESR (mm/h): Mean (SD)

13.79 (13.23)

8.53 (7.01)

0.17

Systolic hypertension (mm Hg): Mean (SD)

121.33 (13.91)

120.08 (11.73)

0.86

Cholesterol (mg/dl): Mean (SD)

196.08 (34.31)

193 (36.42)

0.69

HDL- C (mg/dl): Mean (SD)

55.58 (17.05)

63.88 (20.7)

0.051

Smoking: n (%)

13 (33)

9 (22.5)

0.32

Dyslipidemia: n (%)

21 (53)

17 (42.5)

0.37

Arterial hypertension: n (%)

2 (5)

3 (7.5)

0.99

Obesity (BMI> 35) n (%)

7 (18)

3 (7.5)

0.18

SCORE (%): Mean (SD )

0.2 (0.46)

0.15 (0.43)

0.55

Carotid plaques: n (%)

10 (25)

1 (2.5)

0.003

Bilateral carotid plaques: n (%)

5 (13)

0 (0)

0.02

Arterial stiffness (PWV m/sec): Mean (SD)

6.33 (1.47)

6.13 (1.18)

0.72

Carotid IMT (mm): Mean (SD)

0.579 (0.11)

0.549 (0.10)

0.17




Disclosure: N. Vegas-Revenga, None; J. L. Martín-Varillas, None; S. Armesto, None; M. A. González- López, None; V. Portilla, None; P. Fuentevilla, None; J. Rueda-Gotor, None; C. Fernández-Díaz, None; L. C. Domínguez-Casas, None; B. Atienza-Mateo, None; J. L. Hernández, None; R. Blanco, None; M. A. González-Gay, None; A. Corrales, None.

To cite this abstract in AMA style:

Vegas-Revenga N, Martín-Varillas JL, Armesto S, González- López MA, Portilla V, Fuentevilla P, Rueda-Gotor J, Fernández-Díaz C, Domínguez-Casas LC, Atienza-Mateo B, Hernández JL, Blanco R, González-Gay MA, Corrales A. Increased Prevalence of Subclinical Atherosclerosis in Moderate-Severe Plaque Psoriasis Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/increased-prevalence-of-subclinical-atherosclerosis-in-moderate-severe-plaque-psoriasis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-prevalence-of-subclinical-atherosclerosis-in-moderate-severe-plaque-psoriasis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology